Financial Times

•

Channel • 12 Shows

Technology

Technology

Updated weekly
Business

Business

Updated weekly
Daily News

Daily News

Updated daily
Politics

Politics

Updated weekly
Politics

Politics

Updated weekly
Business News

Business News

Updated weekly
Investing

Investing

Updated twice weekly

13 NOV

Scottish kilts set to enter the bond market

US government shutdown nears an end as House approves funding deal, European carmakers and other industrial companies continue to face “devastating” chip shortages, and Scotland has been handed the same credit rating as the UK, in a boost to Edinburgh as it plans to launch an inaugural bond sale. Plus, an increasing number of wealthy Chinese people are trying to set up family offices and secure residency in the Gulf, rather than Singapore. Mentioned in this podcast: US government shutdown nears an end as House approves funding deal Europe’s carmakers face ‘devastating’ chip crisis as Nexperia supply crunch continues Scotland handed same credit rating as UK ahead of debut ‘kilts’ sale Wealthy Chinese sidestep Singapore for Dubai US mints last penny after Trump killed coin Credit: Myles McCormick Today’s FT News Briefing was produced by Lulu Smyth Victoria Craig, Sonja Hutson, and Marc Filippino. Our show was mixed by Kelly Garry. Additional help from Gavin Kallmann, Michael Lello and David da Silva. The FT’s acting co-head of audio is Topher Forhecz. The show’s theme music is by Metaphor Music. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

13 Nov

•

12 min
8 OCT

The economics of birth control. With Martha Bailey

When it comes to women controlling their own economic destinies, perhaps nothing has had a more profound impact than the contraceptive pill. But the US may be on the cusp of change. Earlier this year, the Trump administration froze some federal funding for subsidised access to contraceptive services and more changes are on the horizon. That has made understanding the economic impact of contraception all the more pressing. In this week’s episode, the FT’s Sarah O’Connor speaks to Martha Bailey, economics professor and the director of the California Center for Population Research at UCLA. Sarah O’Connor is employment columnist at the FT. You can read her articles here. Join top FT journalists Chris Giles, Katie Martin, Claire Jones and special guest Lael Brainard on October 23 1200 GMT for an exclusive subscriber webinar, Markets on edge: central banks, bonds and the risks ahead. Register now and put your questions directly to our panel. Visit ft.com/edge Subscribe to The Economics Show on Apple, Spotify, Pocket Casts or wherever you listen. Presented by Sarah O’Connor. Produced by Josh Gabert-Doyon and Lulu Smyth. Manuela Saragosa is the executive producer. Original music and sound design by Breen Turner. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

8 Oct

•

32 min
5 NOV

The $17bn nuclear start-up without any revenue

Publicly-listed Oklo sits at the intersection of two hot areas for Wall Street: artificial intelligence and energy companies. This year alone, Oklo’s share price has jumped more than 400 per cent. But the business hasn’t generated any revenue. It hasn’t built a nuclear reactor, and it hasn’t secured any binding contracts with customers. The FT’s US energy editor Jamie Smyth explains the enthusiasm for Oklo, its links to the Trump administration and whether it can live up to the hype. Clips from New York Stock Exchange, The White House, a16z - - - - - - - - - - - - - - - - - - - - - - - - - - For further reading: Inside Oklo: the $20bn nuclear start-up without any revenue US and investors gambling on unproven nuclear technology, warn experts Donald Trump’s assault on US nuclear watchdog raises safety concerns - - - - - - - - - - - - - - - - - - - - - - - - - - Attend the FT Global Banking Summit, 2-4 December in London: Enter SAVE20 for a 20% discount, register here. - - - - - - - - - - - - - - - - - - - - - - - - - - Follow Jamie Smyth on X (@JamieSmythF), or on Bluesky (@jamiesmythft.bsky.social). Michela Tindera is on X (@mtindera07) and Bluesky (@mtindera.ft.com), or follow her on LinkedIn for updates about the show and more. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

5 Nov

•

23 min
12 NOV

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multibillion-dollar battle for control of biotech start-up Metsera. The FT’s US deals and activism correspondent Oliver Barnes walks through the tussle that’s involved lawsuits, public barbs and political drama. Clips from CNBC, Pfizer, Yahoo Finance - - - - - - - - - - - - - - - - - - - - - - - - - - For further reading and listening: Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk Pfizer shows hardball mettle needed to win in 2025 M&A There is only one winner in the Pfizer Novo Nordisk showdown Ozempic’s unconventional origins - - - - - - - - - - - - - - - - - - - - - - - - - - Attend the FT Global Banking Summit, 2-4 December in London: Enter SAVE20 for a 20% discount, register here. - - - - - - - - - - - - - - - - - - - - - - - - - - Follow Oliver Barnes on X (@mroliverbarnes), or on Bluesky (@mroliverbarnes.bsky.social) Michela Tindera is on X (@mtindera07) and Bluesky (@mtindera.ft.com), or follow her on LinkedIn for updates about the show and more. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

12 Nov

•

26 min
19 NOV

What’s the deal with OpenAI's deals?

OpenAI is entering a new era. It's restructured to add a for-profit arm to its business and has signed more than a trillion dollars’ worth of deals to secure chips and build out data centres. But those huge financial commitments also raise massive questions: How will a heavily loss-making company fund $1.4tn worth of deals with some of the biggest publicly listed companies in the world? And what systemic risks could that come with? The FT's US west coast financial editor Tabby Kinder and venture capital correspondent George Hammond answer the questions everyone's asking. The FT does not use generative AI to voice its podcasts. Clips from Bg2 Pod, CNBC, Yahoo Finance - - - - - - - - - - - - - - - - - - - - - - - - - - For further reading: How OpenAI put itself at the centre of a $1tn network of deals Who owns OpenAI? Blockbuster deals complicate investor payouts OpenAI shunned advisers on $1.5tn of deals How high are OpenAI’s compute costs? Possibly a lot higher than we thought - - - - - - - - - - - - - - - - - - - - - - - - - - Attend the FT Global Banking Summit, December 2-4 in London: Enter SAVE20 for a 20% discount, register here. - - - - - - - - - - - - - - - - - - - - - - - - - - Follow Tabby Kinder (@Tabby_Kinder) and George Hammond (@GeorgeNHammond) on X or on Bluesky (@tabbykinder.bsky.social), (@georgehammond.bsky.social). Behind the Money host Michela Tindera is on X (@mtindera07) and Bluesky (@mtindera.ft.com), or follow her on LinkedIn for updates about the show and more. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

19 Nov

•

26 min
10 DEC

Defying death: The future of forever

Gene and stem cell therapies have been touted as the next phase in the longevity movement, with promises to rejuvenate the body at the cellular level and reverse the effects of ageing. But, as the prospect of life extension moves into the mainstream, it presents big questions for society as a whole. Are we ready for a world where people live much longer lives? In this final episode, the FT’s Michael Peel and Hannah Kuchler dive into the tough moral questions at the heart of the longevity movement. Hannah speaks to the team at Fountain Life, a longevity clinic trying to bring stem cell therapy to the middle classes. We meet Daniel Ives, founder of gene therapy company Shift Bioscience, and Liz Parrish, who has self-experimented with gene therapies through her company, Biovia. Finally, Michael speaks to Arthur Caplan, the head of the ethics board of longevity fund, Hevolution. Free to read: From immortal jellyfish to elephants: scientists probe secrets of long-lived animals Inside the billion-dollar quest to live beyond 100 Gene editing breakthrough promises to boost fight against disease This series of Tech Tonic is hosted by Michael Peel and Hannah Kuchler. It is produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Special thanks to Michela Tindera. Clips: Al Jazeera Balkans, TV France Japon, ABP News, Rome Reports, @Sciencerely The FT does not use generative AI to voice its podcasts. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

10 Dec

•

31 min
8 OCT

Mission to Mars: Elon Musk's 'Starship' enterprise

Elon Musk wants humans to settle on Mars, and his rocket company SpaceX is spending billions of dollars on developing the spacecraft to take us there. The ‘Starship’ is being designed to take astronauts back to the moon, and eventually, on to the red planet. But why is Musk so obsessed with building a colony on Mars, and is he really the man to take us there? The FT’s space industry editor Peggy Hollinger speaks to space experts and Mars enthusiasts about the pull of the red planet, both for scientists and explorers, and how realistic Musk’s vision for humanity as an interplanetary species really is. This episode of Tech Tonic is hosted by Peggy Hollinger and produced by Mischa Frankl-Duval. The senior producer is Edwin Lane and the executive producer is Flo Phillips. Fact checking by Simon Greaves. Sound design is by Breen Turner and Samantha Giovinco. Original Music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Special thanks to Tom Hannen. Clips: SpaceX, AP, Joe Rogan Experience, SXSW, VideoFromSpace, WPLG Local 10, International Astronautical Foundation, BBC Archive, ABC, CGTN, Flagler Live, John F. Kennedy Library Foundation, NasaSpaceFlight/Joshua Adank Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

8 Oct

•

30 min
3 DEC

Business History: The Secret of Southwest’s Success

This week we’re sharing an episode from Business History, a podcast from Pushkin Industries. Former Planet Money hosts Jacob Goldstein and Robert Smith explore what the businesses of the past can teach us about commerce today. In this episode, Goldstein and Smith look at how Southwest Airlines developed a winning formula that forced its competitors to change how they did business — but then the Southwest model fell apart. Find Business History on YouTube or wherever you get your podcasts. Hosted on Acast. See acast.com/privacy for more information.

3 Dec

•

52 min
22 OCT

Mission to Mars: Bad science fiction

For decades, science fiction writers have envisaged colonising Mars, even building cities on the red planet. Advocates for Mars exploration, such as Elon Musk, want to make that vision a reality. But can humans really live in an alien world? The FT’s space industry editor Peggy Hollinger speaks to researchers about the physical and mental pressures astronauts would face living millions of miles from home and to scientists studying the suitability of Mars’ atmosphere and soil. This episode of Tech Tonic is hosted by Peggy Hollinger and produced by Mischa Frankl-Duval. The senior producer is Edwin Lane and the executive producer is Flo Phillips. Fact checking by Lucy Baldwin. Sound design by Breen Turner and Samantha Giovinco. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

22 Oct

•

31 min
3 DEC

Defying death: The longevity lab

Singapore has become a model for longevity-focused healthcare. With an ageing population and citizens willing to spend money on anti-ageing treatments, the government and private companies are spending big on new ways to slow ageing, and help people live healthier for longer. In this episode the FT’s Michael Peel visits the city-state to find out how longevity treatments are moving into the mainstream. He meets venture capitalist Boyang Wang, personal trainer Tiat Lim (‘Singapore’s Benjamin Button’), and longevity clinic founder Allen Law. Plus, we hear from Tan Kiat How, Singapore’s senior minister of state for health, and National University of Singapore professor Andrea Maier. Free to read: ‘Can I lunge my way to eternal life?’ How one supplement sums up the uneasy science of selling youth Singapore’s prime minister warns of ‘messy’ transition to post-American order This series of Tech Tonic is hosted by Hannah Kuchler and Michael Peel. It is produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Special thanks to Owen Walker. The FT does not use generative AI to voice its podcasts. Clips: @channelnewsasia To sign up for free to the new FT Alphaville newsletter on substack, go to ftav.substack.com Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

3 Dec

•

32 min

News, analysis and comment from the Financial Times